https://www.selleckchem.com/pr....oducts/Verteporfin(V
After a period of clinical stabilization, the patient suffered a recurrent and fatal intracranial hemorrhage. Complicated VITT with extremely high anti-PF4-IgG titers over three months can induce recurrent thrombocytopenia despite treatment with IVIG and anticoagulation. Plasma exchange, immunoadsorption, and /or immunosuppressive treatment may be considered in complicated VITT to reduce extraordinarily high levels of anti-PF4-IgG. Long-term therapy in such cases must take the individual bleeding risk and CSVT risk into ac
Beğen
Yorum Yap
Paylaş
